Organon (OGN) Current Taxes (2020 - 2026)
Organon (OGN) recorded quarterly Current Taxes of $77.0 million in Q1 2026, down 9.41% quarter-over-quarter from $85.0 million in Q4 2025, and down 56.25% on a YoY basis from $176.0 million in Q1 2025.
Organon (OGN) Current Taxes (2020 - 2026) Analysis & Trends
Organon's Current Taxes history runs 7 years deep, the most recent figure standing at $77.0 million for Q1 2026.
- In Q1 2026, Current Taxes fell 56.25% year-over-year to $77.0 million; the TTM figure through Mar 2026 stood at $77.0 million (down 56.25% YoY), while the FY2025 annual figure was $85.0 million, down 36.57% from the prior year.
- Current Taxes was $77.0 million for Q1 2026 at Organon, down from $85.0 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $230.0 million in Q3 2024 to a low of $77.0 million in Q1 2026.
- Historically, Current Taxes has averaged $173.2 million across 5 years, with a median of $192.0 million in 2023.
- The sharpest annual moves came in 2024 and 2026: Current Taxes jumped 42.86% in 2024, then slumped 56.25% in 2026.
- A 5-year view of Current Taxes shows it stood at $184.0 million in 2022, then increased by 11.96% to $206.0 million in 2023, then tumbled by 34.95% to $134.0 million in 2024, then plunged by 36.57% to $85.0 million in 2025, then declined by 9.41% to $77.0 million in 2026.
- The last three Current Taxes figures came in at $77.0 million (Q1 2026), $85.0 million (Q4 2025), and $116.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn | -748.24 Mn |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn | 1.09 Bn |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn | - |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn | 3.95 Bn |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | - |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn | 3.13 Bn |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn | - |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn | 77.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.00 Mn |
| Dec 31, 2025 | 85.00 Mn |
| Sep 30, 2025 | 116.00 Mn |
| Jun 30, 2025 | 194.00 Mn |
| Mar 31, 2025 | 176.00 Mn |
| Dec 31, 2024 | 134.00 Mn |
| Sep 30, 2024 | 230.00 Mn |
| Jun 30, 2024 | 201.00 Mn |
| Mar 31, 2024 | 196.00 Mn |
| Dec 31, 2023 | 206.00 Mn |
| Sep 30, 2023 | 161.00 Mn |
| Jun 30, 2023 | 163.00 Mn |
| Mar 31, 2023 | 192.00 Mn |
| Dec 31, 2022 | 184.00 Mn |
| Sep 30, 2022 | 217.00 Mn |
| Jun 30, 2022 | 211.00 Mn |
| Mar 31, 2022 | 202.00 Mn |
| Dec 31, 2021 | 185.00 Mn |
| Sep 30, 2021 | 335.00 Mn |
| Jun 30, 2021 | 218.00 Mn |